Parkinson's: Epidemiology Overview and Insights - ResearchAndMarkets.com

DUBLIN--()--The "Parkinson's: Epidemiology Overview and Insights" report has been added to ResearchAndMarkets.com's offering.

Disease Indication Overview:

This section of the report gives the overview of Parkinson's disease indication in detail. The section highlights the basic definition, causes and symptoms of disease and further details the types of Parkinson's disease. Further details on the profile of Parkinson's patients, Symptoms experienced by the patients, and disease progression in patients are outlined in the report. The report further highlights the multiple methods through which the patient can be diagnosed for Parkinson's disease.

Epidemiology Forecasts to 2024:

This section of the report provides the overview of Parkinson's diagnosed prevalent and treated patients in the US, EU5 (Germany, France, Italy, Spain and UK) and Japan market year wise starting from 2015-2024. The epidemiology numbers in the report have been derived based on numerous studies, survey reports and views of key opinion leaders.

Companies Mentioned

  • GlaxoSmithKline
  • Boehringer Ingelheim
  • Samil Pharmaceutical
  • Adamas Pharmaceuticals
  • ACADIA Pharmaceuticals
  • Ipsen
  • Ono Pharmaceutical
  • Neurocrine Biosciences
  • Fosun International
  • BIAL
  • Eisai
  • Merck KGaA
  • CSL
  • Meiji Holdings
  • Zambon
  • Newron Pharmaceuticals
  • Valeo Pharma
  • US WorldMeds
  • Vernalis
  • Mylan
  • Cephalon
  • Grnenthal Gruppe
  • STADA Arzneimittel
  • Italfarmaco
  • Gen Ila
  • Sumitomo Dainippon Pharma
  • Cynapsus Therapeutics
  • Aquestive Therapeutics
  • Adagio Pharmaceuticals
  • Acorda Therapeutics
  • Civitas Therapeutics
  • Mitsubishi Tanabe Pharma
  • NeuroDerm
  • BioElectron Technology
  • Prothena

Key Topics Covered:

1 Table of Contents

2 Executive Summary

3 Disease Overview

4 Disease Epidemiology

5 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5n8pw6/parkinsons?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs